Treatments that made headlines in 2018

Treatments that made headlines in 2018, Published online: 06 December 2018; doi:10.1038/s41591-018-0292-3

In 2018, drugs for rare conditions such as beta-thalassemia and forms of amyloidosis made it onto the approval mainstage in addition to drugs for more common diseases such as cancer. The gene-editing technology CRISPR slowly made strides into the therapeutic realm, while drugs for Alzheimer’s disease continued to falter, leaving a wide gap that is still in need of filling.

中文翻译：

---

在2018年成为头条新闻的治疗

在2018年成为头条新闻的治疗

在线治疗于2018年成为头条新闻，在线发布：2018年12月6日; doi：10.1038 / s41591-018-0292-3

在2018年，除了用于治疗癌症等较常见疾病的药物外，用于β-地中海贫血和淀粉样变性病等罕见疾病的药物也进入了批准的主要阶段。基因编辑技术CRISPR慢慢进入了治疗领域，而用于治疗阿尔茨海默氏病的药物继续动摇，仍然需要填补一个巨大的空白。